Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Although diagnostic measures and surgical interventions have improved in recent years, the five-year survival rate for patients with advanced HCC remains bleak—a reality that is largely attributable to an...
Main Authors: | Johanna K. DiStefano, Bethany Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/4/486 |
Similar Items
-
Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma
by: Dai T, et al.
Published: (2021-08-01) -
The Role of AKR1B10 in Physiology and Pathophysiology
by: Satoshi Endo, et al.
Published: (2021-05-01) -
Expression of the Aldo-Keto Reductases AKR1B1 and AKR1B10 in Human Cancers.
by: Brian eLaffin, et al.
Published: (2012-06-01) -
AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
by: Marko Hojnik, et al.
Published: (2021-07-01) -
Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
by: Cleverson T. Soares, et al.
Published: (2018-09-01)